| Gwen R Radke, OT | |
|
4319 Nw Urbandale Dr, Urbandale, IA 50322-7910 | |
| (515) 225-4070 | |
| Not Available |
| Full Name | Gwen R Radke |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 4319 Nw Urbandale Dr, Urbandale, Iowa |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962540724 | NPI | - | NPPES |
| 01760 | Other | IA | WELLMARK BCBS OF IOWA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 1220 (Iowa) | Primary |
| Provider Name | Blue Stone Therapy Inc. |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1932797297 PECOS PAC ID: 1850707787 Enrollment ID: O20210301002214 |
News Archive
Genervon Biopharmaceuticals LLC today announced that it has successfully completed its Phase 2a clinical trial for amyotrophic lateral sclerosis ("ALS") disease modification. A full analysis of the trial's results is expected to be completed in the third quarter of 2014, but preliminary data suggests that Genervon's novel, proprietary, multi-target biological drug candidate, GM604, shows significant promise for treating ALS.
Sheree Schrager, PhD, MS, an investigator at Children's Hospital Los Angeles, and fellow investigator, Jeremy Goldbach, PhD, of the USC Suzanne Dworak-Peck School of Social Work, have been awarded $3.7 million by the National Institute on Minority Health and Health Disparities of the NIH to study the behavioral health risks of sexual minority adolescents -those who identify as lesbian, gay or bisexual.
Selcia Ltd today announced the successful completion of a drug discovery project with ExonHit Therapeutics SA, using Selcia's fragment screening technology. Novel and weak affinity hits were identified from Selcia's Fragment Library, using their proprietary CEfrag technique.
Allos Therapeutics, Inc. announced today that the Agreement and Plan of Merger and Reorganization entered into by and among Allos, AMAG and Alamo Acquisition Sub, Inc. on July 19, 2011, as amended on August 8, 2011, has been terminated.
The current COVID-19 pandemic is caused by a novel coronavirus called SARS-CoV-2, or severe acute respiratory syndrome coronavirus 2. Coronavirus disease 2019 (COVID-19) is an infectious disease caused by SARS-CoV-2.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Gwen R Radke, OT 505 N Craig Dr, Cherokee, IA 51012-1107 Ph: (712) 261-5877 | Gwen R Radke, OT 4319 Nw Urbandale Dr, Urbandale, IA 50322-7910 Ph: (515) 225-4070 |
News Archive
Genervon Biopharmaceuticals LLC today announced that it has successfully completed its Phase 2a clinical trial for amyotrophic lateral sclerosis ("ALS") disease modification. A full analysis of the trial's results is expected to be completed in the third quarter of 2014, but preliminary data suggests that Genervon's novel, proprietary, multi-target biological drug candidate, GM604, shows significant promise for treating ALS.
Sheree Schrager, PhD, MS, an investigator at Children's Hospital Los Angeles, and fellow investigator, Jeremy Goldbach, PhD, of the USC Suzanne Dworak-Peck School of Social Work, have been awarded $3.7 million by the National Institute on Minority Health and Health Disparities of the NIH to study the behavioral health risks of sexual minority adolescents -those who identify as lesbian, gay or bisexual.
Selcia Ltd today announced the successful completion of a drug discovery project with ExonHit Therapeutics SA, using Selcia's fragment screening technology. Novel and weak affinity hits were identified from Selcia's Fragment Library, using their proprietary CEfrag technique.
Allos Therapeutics, Inc. announced today that the Agreement and Plan of Merger and Reorganization entered into by and among Allos, AMAG and Alamo Acquisition Sub, Inc. on July 19, 2011, as amended on August 8, 2011, has been terminated.
The current COVID-19 pandemic is caused by a novel coronavirus called SARS-CoV-2, or severe acute respiratory syndrome coronavirus 2. Coronavirus disease 2019 (COVID-19) is an infectious disease caused by SARS-CoV-2.
› Verified 8 days ago
Andrew Vanblair, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 13731 Hickman Rd, Urbandale, IA 50323 Phone: 515-331-9676 | |
Mrs. Jeanne Marie Fung, OTR/L Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 14817 Dellwood Dr, Urbandale, IA 50323 Phone: 515-229-0629 | |
Erin Johnson, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 13731 Hickman Rd, Urbandale, IA 50323 Phone: 515-331-6907 | |
Molly Joanne Manning, OTD Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 4222 161st St, Urbandale, IA 50323 Phone: 515-867-1571 | |
Mrs. Christen Anne Bliss, MOTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 4319 Nw Urbandale Dr, Urbandale, IA 50322 Phone: 515-225-4070 | |
Sarah Gronau, Occupational Therapist Medicare: Medicare Enrolled Practice Location: 4319 Nw Urbandale Dr, Urbandale, IA 50322 Phone: 515-225-4070 | |
Judy Heitmann, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 8000 Douglas Ave, Urbandale, IA 50322 Phone: 515-251-3700 Fax: 515-251-3733 |